Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
C. Rigauts (Ghent, Belgium), J. Aizawa (Anwerp, Belgium), S. Taylor (Adelaide, Australia), G. Rogers (Adelaide, Australia), M. Govaerts (Anwerp, Belgium), P. Cos (Anwerp, Belgium), L. Ostyn (Ghent, Belgium), S. Sims (Adelaide, Australia), E. Vandeplassche (Ghent, Belgium), M. Sze (Ghent, Belgium), Y. Dondelinger (Ghent, Belgium), L. Vereecke (Ghent, Belgium), H. Van Acker (Ghent, Belgium), J. Simpson (New South Wales, Australia), L. Burr (South Brisbane, Australia), A. Willems (GhentBrisbane, Belgium), M. Tunney (Belfast, Ireland), C. Cigana (Milan, Italy), A. Bragonzi (Milan, Italy), T. Coenye (Ghent, Belgium), A. Crabbé (Ghent, Belgium). The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease.. 873

Member's Comments

No comment yet.

Related content which might interest you: Streptococcus pneumoniae augments inflammatory process in asthma model without changing Th2 profile Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells Source: Eur Respir J 2011; 37: 53-64 Year: 2011 Reduced phagocytosis of bacterial pathogens by macrophages from COPD patients Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 A subset of COPD patients defined by lung epithelial IL-6 trans-signalling is associated with neutrophilic inflammation and colonization by Haemophilus influenzae Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Differential inflammatory effects of colonising airway bacteria in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 686s Year: 2004 Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD Year: 2012 The role of pathogenic bacterial colonisation in neutrophilic airways inflammation in severe asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008 The balance of pro- and anti - inflammatory cytokines in Chlamydia pneumoniae infected cells as a marker of inflammatory activity in the pulmonary compartment Source: Eur Respir J 2001; 18: Suppl. 33, 154s Year: 2001 The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia Source: Annual Congress 2006 - Immunology of the airways Year: 2006 The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 The species-specific inflammatory response of colonising bacteria in stable COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Xylitol affects production of virulence factors and biofilm in pseudomonas aeruginosa; effects on respiratory epithelium inflammation. "In vitro" studies Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Acinetobacter lwoffii and lactococcus lactis strains isolated from cowsheds of traditional farms suppress allergic airway inflammation in a mouse model of experimental asthma Source: Eur Respir J 2007; 30: Suppl. 51, 736s Year: 2007 Spontaneous sputum production as a marker of bacterial colonisation in stable COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells Source: Eur Respir J 2008; 32: 1591-1598 Year: 2008